A microarray-based high-throughput in situ tagged immunoprecipitation sequencing technology for diffuse midline glioma

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal cord. Due to the high surgical risks and poor prognosis associated with DMG, treatment options for patients are extremely limited.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup